Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/9054| Title: | 10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial | Authors: | Oguoma, Victor M. Wilson, Nicole Mulholland, Kim Santosham, Mathuram Torzillo, Paul McIntyre, Peter Smith-Vaughan, Heidi Balloch, Anne Chatfield, Mark Lehmann, Deborah Binks, Michael J. Chang, Anne Carapetis, Jonathan Krause, Vicki Andrews, Ross Snelling, Tom Licciardi, Paul Morris, Peter Leach, Amanda Jane |
Issue Date: | 2020 | Journal: | BMJ Open |
| Appears in Sites: | Publication workflow Queensland Health Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.